Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Immunology and Immunopathology|May 1, 1994
Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host diseaseP M Schiltz, R C Giorno, H N ClamanArthritis and Rheumatism|November 1, 1990
Dermal mast cell degranulation in systemic sclerosisJ R Seibold, R C Giorno, H N ClamanArthritis and Rheumatism|December 1, 1991
Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin"H N Claman, R C Giorno, J R SeiboldThe Histochemical Journal|September 1, 1993
Mast cell immunohistochemistry: non-immunological immunostaining mediated by non-specific F(ab')2-mast cell secretory granule interactionP M Schiltz, J Lieber, R C Giorno, et al.The Journal of Allergy and Clinical Immunology|December 1, 1983
Lymphocyte subpopulations in the skin of patients with chronic urticariaY A Mekori, R C Giorno, P Anderson, et al.Bone Marrow Transplantation|July 1, 1995
Liver T cell subsets and adhesion molecules in murine graft-versus-host diseaseC D Howell, D De Victor, J Li, et al.The Journal of Investigative Dermatology|May 1, 1996
Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory responseJ Saloga, D Y Leung, C Reardon, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndromeD Y Leung, R C Giorno, L V Kazemi, et al.Journal of Cutaneous Pathology|October 1, 1987
An immunopathological study of herpes-associated erythema multiformeM T Zaim, R C Giorno, L E Golitz, et al.Arthritis and Rheumatism|May 1, 1988
Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermisM E Pearson, J C Huff, R C Giorno, et al.Pageof 2